• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Coloplast

380.00 DKK

+0.05 %

Less than 1K followers

COLO B

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.05 %
-4.83 %
-15.06 %
-30.45 %
-32.24 %
-40.35 %
-55.25 %
-61.71 %
+710.23 %

Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Read more
Market cap
86.72B DKK
Turnover
96.27M DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
18.8.
2026

Interim report Q3'26

3.11.
2026

Annual report '26

1.12.
2026

General meeting '26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Press release6/3/2026, 1:00 PM

Coloplast’s Next Generation Inflatable Penile Prosthesis Approved by the FDA – can help millions of men

Coloplast
Regulatory press release5/12/2026, 5:30 AM

Coloplast A/S - Announcement no. 05/2026 - Interim Financial Report, H1 2025/26

Coloplast
Press release5/1/2026, 1:00 PM

Coloplast Receives Innovative Technology Contract from Vizient for Biatain® Silicone Fit

Coloplast

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release4/23/2026, 5:50 PM

Coloplast A/S - Coloplast revises financial guidance for FY 2025/26 to reflect reduced growth outlook for Kerecis

Coloplast
Press release4/22/2026, 5:08 PM

Coloplast A/S - H1 2025/26 Earnings Release - Invitation for conference call on 12 May 2026 at 11:00 CEST

Coloplast
Regulatory press release3/12/2026, 4:01 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release3/11/2026, 6:25 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release3/10/2026, 2:39 PM

Coloplast A/S - Allocation of Share Options

Coloplast
Regulatory press release3/9/2026, 7:50 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release3/8/2026, 9:48 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release3/5/2026, 5:04 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Coloplast
Regulatory press release3/4/2026, 6:52 PM

Coloplast appoints Gavin Wood as new CEO

Coloplast
Regulatory press release2/11/2026, 2:36 PM

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast
Regulatory press release2/6/2026, 6:30 AM

Coloplast A/S - Interim Financial Report, Q1 2025/26

Coloplast
Press release1/26/2026, 12:02 PM

Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET

Coloplast
Regulatory press release12/18/2025, 2:00 PM

Coloplast announces changes to Executive Leadership Team

Coloplast
Regulatory press release12/4/2025, 4:50 PM

Coloplast A/S - Decisions at the Annual General Meeting 2025

Coloplast
Regulatory press release11/11/2025, 9:12 AM

Coloplast A/S - Notice of Annual General Meeting 2025

Coloplast
Regulatory press release11/4/2025, 6:32 AM

Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25

Coloplast
Regulatory press release11/4/2025, 6:31 AM

Coloplast A/S - Full-Year Financial Results 2024/25

Coloplast